Quest Diagnostics

Forecast & Rating18 analysts currently cover Quest Diagnostics, with about 50.0% giving a positive rating — meaning they expect the stock to rise. The average price target is $257.27, about 2.2% upside from the current price of $251.82. Price targets span a fair range, indicating some disagreement among institutions. Historically, about 91.2% of past price targets were eventually met, which adds credibility. For you, this means institutional views on Quest Diagnostics are split — bulls and bears coexist, so you'll need to weigh it against your own judgment. Data as of Oct 28, 2026; for reference only and not investment advice.